A phase III study of voclosporin in Japanese and non-Japanese patients.
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Voclosporin (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- 14 Feb 2017 According to an Aurinia Pharmaceuticals Media Release, data from Ethnic Bridging Study (see profile 271230) supports use of the 23.7mg BID voclosporin dose in this trial.
- 09 Sep 2016 New trial record